Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed)
ID: 355241Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed)" aimed at enhancing research capabilities in mental health through improved data standardization from wearable technologies. The initiative seeks to establish universal standards for data from personal tracking devices, similar to the DICOM format used in medical imaging, to facilitate data aggregation and analysis for mental illness biomarkers. Eligible applicants include educational institutions, nonprofits, and government entities, with a project duration of up to four years and a budget reflecting actual needs. The application period opens on May 10, 2025, with proposals due by 5:00 PM local time on June 10, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, in collaboration with the National Institutes of Health (NIH) and specifically the National Institute of Mental Health (NIMH), is offering a funding opportunity aimed at standardizing data and metadata from wearable devices to enhance research related to mental illness. The initiative seeks to address challenges related to disparate data formats from various manufacturers, facilitating easier data aggregation and analysis, and requires collaboration with device manufacturers and the research community. Applications are due by June 10, 2025, with a maximum project period of four years, and the opportunity is open to a wide range of eligible organizations, including academic institutions and nonprofits.
    Similar Opportunities
    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the funding opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications," aimed at fostering the development of innovative brain stimulation devices or enhancing existing FDA-approved devices for treating mental health disorders. The initiative seeks applications from multi-disciplinary teams with expertise in neuroscience, engineering, clinical practices, and regulatory matters, focusing on creating devices that offer improved spatial and temporal resolution compared to current technologies. This funding opportunity is critical for advancing treatment methods in mental health care, with no budget limits as long as costs align with project needs, and applications are due by January 7, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications," aimed at advancing the development of innovative brain stimulation devices for mental health treatment. This grant supports projects that either create novel brain stimulation technologies or significantly enhance existing FDA-approved devices, focusing on improving spatial and temporal precision and enabling multi-focal approaches for effective treatment delivery. The initiative is crucial for addressing clinical limitations in mental health technologies and encourages collaboration among multidisciplinary teams with expertise in neuroscience, engineering, and regulatory affairs. Interested applicants can apply for up to $275,000 over a two-year project period, with applications due by January 7, 2025. For further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-038.html.
    Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Laboratories to Optimize Digital Health" grant, aimed at enhancing the reach and effectiveness of digital mental health interventions. This initiative focuses on innovative research projects that leverage established digital health platforms to conduct clinical trials, ultimately seeking to address health disparities and improve mental health outcomes. The funding opportunity encourages collaboration and the development of scalable, technology-driven solutions, with no budget limits and a maximum project period of four years. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with applications due by March 5, 2025.
    Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Clinical Studies of Mental Illness (Collaborative R01)" aimed at supporting multidisciplinary clinical studies focused on mental health, particularly in areas such as genetics, biomarkers, and various mental illnesses. This initiative encourages collaboration across multiple sites to enhance sample sizes and diversity in participant recruitment, specifically targeting health disparity populations. The program allows for a project period of up to five years with no explicit budget limits, although proposed budgets must be well justified. Interested applicants, including various educational and nonprofit institutions, should submit their applications by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For more details, applicants can refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-050.html.
    Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Laboratories to Optimize Digital Health" initiative, aimed at enhancing the reach and effectiveness of digital mental health interventions through innovative research projects. This funding opportunity focuses on developing digital health test beds to optimize existing evidence-based interventions, particularly targeting vulnerable populations and addressing health disparities. The initiative supports clinical trials and encourages collaboration between software developers and researchers to understand the mechanisms of action behind these interventions. Applications open on January 5, 2025, with multiple due dates leading to awards expected to begin in July 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at NIH Grants.
    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders" (FOA Number PAR-23-093). This grant aims to promote research focused on invasive neural recording studies that explore the neural circuitry underlying mental health disorders, with an emphasis on high translational potential in understanding moods, cognitive functions, and behaviors. The initiative encourages collaboration among diverse research teams in fields such as neurosurgery, electrophysiology, and psychology, while specifically excluding general neuroscience studies that do not focus on mental health or intervention development. Interested applicants can submit proposals until January 7, 2025, with no specific budget limits for projects that may extend up to five years; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-093.html.
    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)." This funding initiative aims to support invasive neural recording studies that address mental health-related questions, focusing on understanding the neural circuitry and dynamics underlying complex behaviors, emotions, and cognitive functions. The R21 grant mechanism encourages innovative, short-term research proposals with a budget of up to $275,000 over two years, while emphasizing the importance of diverse research teams from various clinical fields. Interested applicants should note that the application deadline is January 7, 2025, and can find further details and guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity titled "Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)." This grant aims to support innovative research that enhances the delivery and quality of mental health services, particularly for underserved populations, by addressing issues such as access, usability, quality, and scalability of these services. Eligible applicants include a wide range of organizations, including educational institutions, non-profits, and governmental bodies, with a focus on projects that incorporate community input and comply with NIH guidelines. Interested parties should note that the application deadline is January 7, 2025, and further details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-095.html. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    Translational Neural Devices (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Neural Devices (R61/R33 - Clinical Trial Optional)" aimed at advancing the development of therapeutic and diagnostic devices for neurological and neuromuscular disorders. This initiative encourages investigators to engage in translational activities and small clinical studies, focusing on the implementation of clinical prototype devices, non-clinical safety and efficacy testing, and obtaining necessary regulatory approvals for clinical trials. The program emphasizes a milestone-driven approach, requiring collaboration with NIH staff throughout the project, and aims to address health disparities in neurological health. Interested applicants, including various educational and community organizations, must submit their proposals by January 28, 2027, and can find additional information and application guidelines at NIH Grants.